Chemcrux Enterprises Ltd

AGM notice and AR access

• Purpose: Notify shareholders of web-links to Annual Report 2025-26 and AGM notice.
• AGM date: 17 September 2026 at 02:00 PM IST via VC/OAVM.
• Access method: Notice and Annual Report accessible via web-links and investor portal.
• Email registration: Shareholders without registered email to register with Depository Participants.
• Compliance reference: Regulation 36(1)(b) of SEBI LODR noted.
• Website: AR and AGM Notice hosted on chemcrux.com and Investors Info page.

Dividend and TDS update

• Board recommended dividend of Re 1 per equity share for year ended 31 March 2026.
• AGM on 17 September 2026; record date 10 September 2026.
• Dividend paid within 30 days of AGM, by 17 October 2026, electronically if bank details are updated.
• TDS on dividend: 10% for resident taxpayers; 20% for non-residents, plus surcharge/cess.
• Resident individuals: no TDS if aggregate dividend per folio in 2026-27 ≤ Rs 10,000.
• Form 121 can be used for nil/lower TDS for eligible residents; Company may reject if requirements unmet.
• PAN-Aadhaar linkage mandatory; unlinked PAN triggers higher TDS rate (20%).
• Nil/lower TDS for insurers, mutual funds, AIFs, NPS trusts with self-declarations and PAN.
• Non-residents may claim DTAA benefits with TRC, Form 41, and related declarations; rate remains 20% otherwise.
• Documents must be submitted by 10 September 2026; no post-deadline tax determinations.

Cessations of Independent Directors

• Bhanubhai Patel, Independent Director, ceased 23 Aug 2026; completion after two five-year terms; no other material reasons.
• Shailesh Patel, Independent Director, ceased 23 Aug 2026; completion after two five-year terms; no other material reasons.

AGM & closure

• 30th AGM scheduled 17 September 2026 at 2:00 PM IST via video conference.
• Book closure period: 11 September 2026 to 17 September 2026 inclusive.

Voting, cut-offs, and record dates

• Cut-off date for AGM notice list: 14 August 2026.
• Electronic voting cut-off: 10 September 2026.
• Record date for dividend eligibility: 10 September 2026.
• E-voting period: 14 September 2026 9:00 AM to 16 September 2026 5:00 PM.

Record date and dividend details

• Record date: 10 September 2026 for equity shares to determine dividend entitlement.
• Dividend, if declared, will be final and approved at the 30th AGM on 17 September 2026.
• Payment will be made within 30 days of the AGM, by 17 October 2026.
• Entitlement applies to members in the register as of close of business 10 September 2026.
• Dividend is subject to section 126 of the Companies Act, 2013.

AGM Details

• AGM on 17 September 2026 at 02:00 PM IST via VC/OAVM.
• Deemed venue is the Company’s registered office.
• Record date for dividend and e-voting: 10 September 2026.
• Book closure: 11–17 September 2026.
• Final dividend proposed at 10% (Re 1 per equity share).
• Dividend entitlement cut-off for e-voting: 10 September 2026.

Ordinary Business Resolutions

• Adoption of standalone financial statements for year ended 31 March 2026.
• Adoption of consolidated financial statements for year ended 31 March 2026.
• Final dividend of Re 1 per equity share (10%).
• Re-appointment of Vipul Sanghvi as Director, retiring by rotation.

Special Business Resolutions

• Remuneration to Girishkumar Shah (Executive Chairman) for 2 years from Jan 2027; cap Rs 3 crore.
• Remuneration to Sanjay Marathe (Managing Director) for 2 years from Jan 2027; cap Rs 3 crore.
• Regularisation of Zarna Pankaj Thakar as Independent Director for 1 year.

Financials at a glance

• Standalone revenue from operations: 8,257.92 Lakhs (FY2025-26).
• Standalone total revenue: 8,525.25 Lakhs; PAT: 544.97 Lakhs.
• Consolidated revenue: 8,267.13 Lakhs; PAT: 373.08 Lakhs.
• Standalone EPS: 3.68; Consolidated EPS: 2.52.
• EBITDA (standalone): 1,292.18 Lakhs.
• Final dividend proposed: Re 1 per equity share; payout 148.09 Lakhs.

Capital structure & liquidity

• Standalone debt-to-equity: 0.27; Consolidated: 0.44.
• Current ratio: Standalone 2.26.
• Consolidated net debt-to-equity improved to 0.44 from 0.56.
• Operating cash flow: Standalone 1,220.17 Lakhs; Consolidated 1,385.24 Lakhs.

Operations and capacity

• Ankleshwar expansion completed; capacity now 250 KL.
• Kalichem Private Limited became 100% subsidiary on 27 Feb 2025.
• GPCB approval to add inorganic products at Kalichem; production after CCA.
• Single segment focus: Bulk Drug Intermediates; downstream derivatives expansion.

Governance & risk

• Board comprises eight directors; four Independent Directors.
• CSR Committee dissolved on 05 February 2026.
• Auditors: Naresh & Co; Secretarial: KSPS & Co LLP; Internal audits ongoing.
• Remuneration approvals via Special Resolutions; ESOP 2025 granted 1,07,700 options.
• CEO/CFO certification; Board evaluation; Independent Directors declarations.

Shareholder matters & CSR

• 30th AGM via VC/OAVM on 17 September 2026; record date 10 September 2026.
• Annual report available online; remote e-voting Sept 14-16, 2026.
• CSR spend Rs 26.09 Lakhs; CSR policy on company site; activities disclosed.
• ESOP 2025: 1,07,700 options granted; 18,95,200 options outstanding.

Subsidiaries & consolidation

• Kalichem Private Limited consolidated as wholly-owned subsidiary for full year.
• Previous year: Kalichem JV; now consolidation changed post Feb 2025.
• Consolidated results reflect Kalichem as subsidiary from Feb 27, 2025; comparatives not strictly comparable.

Audits & controls

• Audits: Standalone and Consolidated unqualified; no material qualifications.
• Secretarial audit: Annexures; no material compliance issues.
• Internal controls deemed adequate; governance processes in place.

Meeting Details

• Board meeting scheduled for 04 August 2026 at 05:00 PM at registered office, Vadodara.

Key Agenda Items

• To consider and approve unaudited financial results for quarter ended 30 June 2026 (Q1 FY2026-27).
• To consider any other business/agenda.

Other Notes

• Trading window closed from 01 July 2026 until 48 hours after results declared on 04 August 2026.